Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-13 4:06 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Kauffman Michael | 3,921,434 5.77% | 314,994 (+8.73%) | View |
2020-02-13 1:43 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | STATE STREET CORP STT | 3,228,366 5.14% | 3,228,366 (New Position) | View |
2020-02-12 4:19 pm Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,787,000 6.03% | -213,000 (-5.33%) | View |
2020-02-06 5:07 pm Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | INTEGRATED CORE STRATEGIES (US) LLC | 13,496 0% | -3,359,070 (-99.60%) | View |
2020-02-05 12:16 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | BlackRock Inc. BLK | 4,768,926 7.6% | 511,014 (+12.00%) | View |
2019-11-18 5:22 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,000,000 6.37% | 4,000,000 (New Position) | View |
2019-11-08 09:03 am Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | WELLINGTON MANAGEMENT GROUP LLP | 1,571,052 2.5% | -6,645,729 (-80.88%) | View |
2019-07-23 5:00 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | INTEGRATED CORE STRATEGIES (US) LLC | 3,372,566 5.5% | 3,372,566 (New Position) | View |